Kazia Therapeutics (KZIA) Return on Capital Employed Growth (1y) (2012 - 2017)

Kazia Therapeutics (KZIA) Return on Capital Employed Growth (1y) (2012 - 2017) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 1,648.00
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 31,429.00
4 BeOne Medicines 471.57 Bn 466.77 Bn 1.35 Bn 1,805.00
5 Vertex Pharmaceuticals 122.01 Bn 114.76 Bn 2.59 Bn 2,503.00
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn -105.00
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn 2,400.00
10 Kazia Therapeutics 19.18 Bn 19.18 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2017 -4,994.00
Dec 31, 2016 -10,071.00
Dec 31, 2015 -261,359.00
Dec 31, 2014 257,793.00
Dec 31, 2013 5,264.00
Dec 31, 2012 -5,522.00